Friend or foe: the role of microRNA in chemotherapy resistance.
about
miR-196, an Emerging Cancer Biomarker for Digestive Tract CancersBioinformatic tools for microRNA dissectionExploring circulating micro-RNA in the neoadjuvant treatment of breast cancerDown-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression.Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status.Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type.MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval.Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-3 and vimentin.Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients.MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.Sexual Dimorphism of miRNAs Secreted by Bovine In vitro-produced Embryos.Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers.MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.miRNAs: mediators of ErbB family targeted therapy resistance.Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells.Autophagy and multidrug resistance in cancer.PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.MicroRNA-in drug resistance.WBSCR22 confers oxaliplatin resistance in human colorectal cancer.MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells.Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells.Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.Negative Regulation of PTEN by MicroRNA-221 and Its Association with Drug Resistance and Cellular Senescence in Lung Cancer Cells.MiRNA-150-3p targets SP1 and suppresses the growth of glioma cells.Dendrimers Show Promise for siRNA and microRNA Therapeutics
P2860
Q26748577-1B79DC5A-3433-4CFB-B516-2368EA7583D9Q27004412-96BF0633-54B4-40E1-969D-EB5D7D6EDDE6Q28066481-662D4144-9B96-4F42-95C4-601E97A4ABA1Q33677872-D9CDE0AB-CB2D-423C-A1C2-0193A4ECF034Q34917987-BCC950C9-55DB-45E8-B5E4-623AD6863AF4Q35051303-CF220D3A-B84C-4C8B-BC0A-92BC4BA3F160Q35140553-75F16C61-3E38-4F5D-A1BF-6BCBF21DE094Q35364435-E6E8F447-7D7D-430D-B47A-704066C65E17Q35596547-53AC993A-60B3-4E93-A355-47FE41243362Q36400009-B0BB3C52-966A-4004-8613-016D627077AFQ36629393-3B46F912-4BC2-4DC6-8166-05C04C858678Q37736087-D97AA913-E62A-4C25-838E-EBB21140A5CDQ38109551-621A6AAB-B2BF-4980-9734-547308C5E3C9Q38202662-E999E5DB-A50A-4B55-9486-9638C29F3792Q38244277-85A1B6BF-C24E-488A-97C9-AB61BBBAF38DQ38706022-9A6D0653-CFE6-4BEE-860C-48E7C7315CAFQ38862227-B0A9EC25-0A20-435D-8148-592F75400FA2Q38881549-07E54257-7AEA-4681-A458-45226B645CA7Q38998300-0951D410-0BC6-4624-A876-0A186DA921A8Q39395779-45024029-6BAA-4979-A6EB-61EA43754F45Q40853718-0ED1662E-34FC-46A2-A4D5-581214636DC6Q43107552-93EDF234-C3D8-400C-8031-5696EFCB6347Q46262349-DA381724-739E-4422-B116-D0AA4BB0DDCFQ47165781-65F60A1C-BF36-428A-8A63-A7FD83FC13B6Q47216949-5CBF6953-567B-4C1F-9BF9-947BABEF42D7Q51502591-30216B7D-B696-4E74-BEDA-E1F6CD408FC3Q52893098-99E56508-5CC6-41D5-869C-85C2D6108C63Q54980098-AD90C9A2-F3DE-4847-BB49-D4DD25123D60Q55457308-97ED35E4-3C17-4FF5-9BD7-E421D5BEC79BQ58794827-FE0E5989-B0F4-4346-AE2F-3453239CAF63
P2860
Friend or foe: the role of microRNA in chemotherapy resistance.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Friend or foe: the role of microRNA in chemotherapy resistance.
@en
type
label
Friend or foe: the role of microRNA in chemotherapy resistance.
@en
prefLabel
Friend or foe: the role of microRNA in chemotherapy resistance.
@en
P2860
P921
P356
P1476
Friend or foe: the role of microRNA in chemotherapy resistance.
@en
P2093
Burton B Yang
P2860
P2888
P304
P356
10.1038/APS.2013.35
P5008
P577
2013-04-29T00:00:00Z
2013-07-01T00:00:00Z
P5875
P6179
1037251119